View Item 

Show simple item record

C9 ORF 72 expansion in a family with bipolar disorder

dc.contributor.authorMeisler, Miriam H.en_US
dc.contributor.authorGrant, Adrienne E.en_US
dc.contributor.authorJones, Julie M.en_US
dc.contributor.authorLenk, Guy M.en_US
dc.contributor.authorHe, Fangen_US
dc.contributor.authorTodd, Peter K.en_US
dc.contributor.authorKamali, Masouden_US
dc.contributor.authorAlbin, Roger L.en_US
dc.contributor.authorLieberman, Andrew P.en_US
dc.contributor.authorLangenecker, Scott A.en_US
dc.contributor.authorMcInnis, Melvin G.en_US
dc.date.accessioned2013-06-18T18:33:31Z
dc.date.available2014-07-01T15:53:31Zen_US
dc.date.issued2013-05en_US
dc.identifier.citationMeisler, Miriam H; Grant, Adrienne E; Jones, Julie M; Lenk, Guy M; He, Fang; Todd, Peter K; Kamali, Masoud; Albin, Roger L; Lieberman, Andrew P; Langenecker, Scott A; McInnis, Melvin G (2013). "C9 ORF 72 expansion in a family with bipolar disorder." Bipolar Disorders 15(3): 326-332. <http://hdl.handle.net/2027.42/98405>en_US
dc.identifier.issn1398-5647en_US
dc.identifier.issn1399-5618en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98405
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherAtypical Bipolaren_US
dc.subject.otherC9 ORF 72en_US
dc.subject.otherRepeat Expansionen_US
dc.titleC9 ORF 72 expansion in a family with bipolar disorderen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychologyen_US
dc.subject.hlbtoplevelSocial Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23551834en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98405/1/bdi12063.pdf
dc.identifier.doi10.1111/bdi.12063en_US
dc.identifier.sourceBipolar Disordersen_US
dc.identifier.citedreferencePamphlett R, Cheong PL, Trent RJ, Yu B. Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study. NeuroReport 2012; 23: 556 – 559.en_US
dc.identifier.citedreferenceSnowden JS, Rollinson S, Thompson JC et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012; 135: 693 – 708.en_US
dc.identifier.citedreferenceTakada LT, Pimentel ML, Dejesus‐Hernandez M et al. Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation. Arch Neurol 2012; 69: 1149 – 1153.en_US
dc.identifier.citedreferenceRanum LP, Cooper TA. RNA‐mediated neuromuscular disorders. Ann. Rev Neurosci 2006; 29: 259 – 277.en_US
dc.identifier.citedreferenceSaluto A, Brussino A, Tassone F et al. An enhanced polymerase chain reaction assay to detect pre‐ and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn 2005; 7: 605 – 612.en_US
dc.identifier.citedreferenceLangenecker SA, Saunders EF, Kade AM, Ransom MT, McInnis MG. Intermediate: cognitive phenotypes in bipolar disorder. J Affect Disord 2010; 122: 285 – 293.en_US
dc.identifier.citedreferenceRenton AE, Majounie E, Waite A et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21‐linked ALS‐FTD. Neuron 2011; 72: 257 – 268.en_US
dc.identifier.citedreferenceGijselinck I, Van Langenhove T, van der Zee J et al. A C9orf72 promoter repeat expansion in a Flanders‐Belgian cohort with disorders of the frontotemporal lobar degeneration‐amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 2012; 11: 54 – 65.en_US
dc.identifier.citedreferenceDeJesus‐Hernandez M, Mackenzie IR, Boeve BF et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p‐linked FTD and ALS. Neuron 2011; 72: 245 – 256.en_US
dc.identifier.citedreferenceSmith BN, Newhouse S, Shatunov A et al. The C9ORF72 expansion mutation is a common cause of ALS±FTD in Europe and has a single founder. Eur J Hum Genet 2013; 21: 102 – 108.en_US
dc.identifier.citedreferenceMajounie E, Renton AE, Mok K et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross‐sectional study. Lancet Neurol 2012; 11: 323 – 330.en_US
dc.identifier.citedreferenceLindquist S, Duno M, Batbayli M et al. Corticobasal and ataxia syndromes widen the spectrumof C9ORF72 hexanucleotide expansion disease. Clin Genet 2013; 83: 279 – 283.en_US
dc.identifier.citedreferenceArighi A, Fumagalli GG, Jacini F et al. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J Alzheimers Dis 2012; 31: 447 – 452.en_US
dc.identifier.citedreferenceNopoulos PC, Aylward EH, Ross CA et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 2011; 134: 137 – 142.en_US
dc.identifier.citedreferenceSavica R, Adeli A, Vemuri P et al. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol 2012; 69: 1164 – 1169.en_US
dc.identifier.citedreferenceMorales F, Couto JM, Higham CF et al. Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum Mol Genet 2012; 21: 3558 – 3567.en_US
dc.identifier.citedreferenceAshizawa T, Monckton DG, Vaishnav S, Patel BJ, Voskova A, Caskey CT. Instability of the expanded (CTG)n repeats in the myotonin protein kinase gene in cultured lymphoblastoid cell lines from patients with myotonic dystrophy. Genomics 1996; 36: 47 – 53.en_US
dc.identifier.citedreferenceMcInnis MG, McMahon FJ, Chase G, Simpson SG, Ross CA, DePaulo JR Jr. Anticipation in bipolar affective disorder. Am J Hum Genet 1993; 53: 385 – 390.en_US
dc.identifier.citedreferencePavlovic A, Marley J, Sivakumar V. Development of frontotemporal dementia in a case of bipolar affective disorder: is there a link? BMJ Case Rep 2011; doi: 10.1136/bcr.09.2010.3303.en_US
dc.identifier.citedreferenceGalvez‐Andres A, Blasco‐Fontecilla H, Gonzalez‐Parra S, Molina JD, Padin JM, Rodriguez RH. Secondary bipolar disorder and Diogenes syndrome in frontotemporal dementia: behavioral improvement with quetiapine and sodium valproate. J Clin Psychopharmacol 2007; 27: 722 – 723.en_US
dc.identifier.citedreferenceHyman BT, Phelps CH, Beach TG et al. National Institute on Aging‐Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012; 8: 1 – 13.en_US
dc.identifier.citedreferenceBurke JF, Albin RL, Koeppe RA et al. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain 2011; 134: 1647 – 1657.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bdi12063.pdf
Size:
301.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.